Robeco Institutional Asset Management B.V. Zai Lab LTD Transaction History

Robeco Institutional Asset Management B.V.

  • $51.9 Billion
  • Q4 2024

A detailed history of Robeco Institutional Asset Management B.V. transactions in Zai Lab LTD stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 52,035 shares of ZLAB stock, worth $1.94 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
52,035
Previous 52,035 -0.0%
Holding current value
$1.94 Million
Previous $1.26 Million 8.44%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024
SELL
$13.72 - $21.55 $13,075 - $20,537
-953 Reduced 1.8%
52,035 $901,000
Q1 2024

Apr 24, 2024
SELL
$15.95 - $26.8 $95,859 - $161,068
-6,010 Reduced 10.19%
52,988 $848,000
Q4 2023

Feb 14, 2024
BUY
$22.97 - $30.58 $1.36 Million - $1.8 Million
58,998 New
58,998 $1.61 Million
Q4 2023

Feb 08, 2024
SELL
$22.97 - $30.58 $1.36 Million - $1.8 Million
-58,998 Closed
0 $59 Million
Q3 2023

Oct 23, 2023
SELL
$22.72 - $31.49 $3.13 Million - $4.34 Million
-137,688 Reduced 70.0%
58,998 $1.43 Million
Q1 2023

May 03, 2023
SELL
$30.21 - $48.1 $335,904 - $534,823
-11,119 Reduced 5.35%
196,686 $6.54 Million
Q4 2022

Feb 06, 2023
BUY
$22.28 - $38.71 $4.63 Million - $8.04 Million
207,805 New
207,805 $6.38 Million

Others Institutions Holding ZLAB

# of Institutions
145
Shares Held
46.3M
Call Options Held
103K
Put Options Held
439K
View Full List

About Zai Lab Ltd

ZLAB Quotes by TradingView
  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $3.65B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Robeco Institutional Asset Management B.V. Portfolio

Follow Robeco Institutional Asset Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email